D. Scharton

发表

Spike mutation D614G alters SARS-CoV-2 fitness

Vineet D. Menachery, S. Weaver, Xuping Xie, 2020, Nature.

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Vineet D. Menachery, S. Lindstrom, S. Weaver, 2020, Emerging infectious diseases.

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility

Vineet D. Menachery, S. Weaver, Xuping Xie, 2020, Nature.

Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

Shinji Makino, Brian Lynch, Scott C. Weaver, 2020, bioRxiv.

The N501Y spike substitution enhances SARS-CoV-2 infection and transmission

Vineet D. Menachery, S. Weaver, Xuping Xie, 2021, Nature.

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis

Vineet D. Menachery, S. Weaver, Xuping Xie, 2021, bioRxiv.

Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.

B. Gowen, J. Westover, K. Bailey, 2014, Antiviral research.

MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters

B. Gowen, J. Westover, E. Sefing, 2015, Front. Microbiol..

Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.

B. Gowen, J. Westover, K. Bailey, 2013, Antiviral research.

Antiviral Activity of Favipiravir (T-705) Against Lethal Rift Valley Fever Virus Infection in Hamsters

Dionna Scharton, D. Scharton, 2014 .

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis

Vineet D. Menachery, S. Weaver, Xuping Xie, 2022, PLoS pathogens.

Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models

D. Weissman, S. Weaver, P. Shi, 2022, Science Translational Medicine.

Combinatorial mRNA vaccination enhances protection against SARS-CoV-2 delta variant

D. Weissman, S. Weaver, P. Shi, 2021, bioRxiv.

Single-Dose Intranasal Treatment with DEF201 (Adenovirus Vectored Consensus Interferon) Prevents Lethal Disease Due to Rift Valley Fever Virus Challenge

B. Gowen, E. Sefing, K. Bailey, 2014, Viruses.

The N501Y spike substitution enhances SARS-CoV-2 transmission

Vineet D. Menachery, S. Weaver, Xuping Xie, 2021, bioRxiv.

Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness

S. Weaver, Xuping Xie, P. Shi, 2021, Nature.

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility

Vineet D. Menachery, S. Weaver, Xuping Xie, 2020, Research Square.

QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis

Vineet D. Menachery, S. Weaver, V. Menachery, 2021, bioRxiv.

SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3

Vineet D. Menachery, M. Daugherty, S. Weaver, 2023, Journal of virology.

SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3

Vineet D. Menachery, M. Daugherty, S. Weaver, 2022, bioRxiv.

Rift Valley Fever Virus Infection in Golden Syrian Hamsters

B. Gowen, J. Westover, K. Bailey, 2015, PloS one.

Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters

S. Weaver, Jianying Liu, Jessica A. Plante, 2023, Nature communications.

Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients

Vineet D. Menachery, S. Weaver, V. Menachery, 2022, Viruses.

Potential of Ilhéus virus to emerge

S. Weaver, Sasha R. Azar, S. Rossi, 2023, bioRxiv.

Yellow Fever Emergence: Role of Heterologous Flavivirus Immunity in Preventing Urban Transmission

B. Drumond, Sasha R. Azar, Jessica A. Plante, 2024, bioRxiv.